Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • December 2020 (Revised January 2022)
  • Supplement
  • HBS Case Collection

Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (B)

By: Linda A. Hill and Emily Tedards
  • Format:Print
  • | Language:English
  • | Pages:27
ShareBar

Abstract

In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone three large-scale mergers and acquisitions. As Ku and his new leadership team set out to build a proactive, end-to-end, digital and physical clinical supply chain, they put in place a “Patients First” culture, developed their digital capabilities, and built out their global footprint.
By 2019, GCS had made significant progress toward becoming the agile, innovative organization necessary to support Pfizer’s new ambition to focus exclusively on developing innovative medicines and vaccines. Ku and his leadership team felt the time had come to implement a new cross-functional decision-making hub. They also decided to pilot a 24-hour, 5 day a week workforce model with a team of clinical pharmacists in Manila. Just as they were beginning to onboard their first hires, COVID-19 struck. GCS found itself on the front lines, having to supply Pfizer’s vaccine candidate and investigational antiviral studies, while also ensuring continuity of clinical supply to hundreds of other trials across the globe. By July 2020, the five-person Manila team—all of which had been on-boarded virtually—had come to play a critical role in GCS’s productivity. With Phase 3 of the vaccine candidate trial looming, Ku and his leadership team had decided to double the size of the Manila team by the end of 2020. The question was, who would lead the team?

Keywords

Digital Technology; Customer-centricity; Innovation; Customer Focus; Talent; Talent Management; Leadership; Innovation and Invention; Transformation; Organizational Culture; Customer Focus and Relationships; Change Management; Talent and Talent Management; Supply Chain; Mission and Purpose

Citation

Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (B)." Harvard Business School Supplement 421-037, December 2020. (Revised January 2022.)
  • Purchase

About The Author

Linda A. Hill

Organizational Behavior
→More Publications

Related Work

    • December 2020 (Revised January 2022)
    • Faculty Research

    Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (B)

    By: Linda A. Hill and Emily Tedards
Related Work
  • Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (B) By: Linda A. Hill and Emily Tedards
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College